Skip to main content

Prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin®) in acute respiratory tract infections

European Journal of Clinical Pharmacology volume 7, pages 415–419 (1974)Cite this article

Summary

Two large scale, double-blind field trials were conducted to test the efficacy of Impulsin (N-2-hydroxyethyl palmitamide) in reducing the incidence and severity of respiratory tract infections. The results suggested that repeated daily intake of Impulsin 30 mg per kg helped to prevent virus infections of the respiratory tract, since it produced a statistically significant reduction in the incidence of illness. Prophylactic treatment with Impulsin markedly diminished the number of episodes of fever, headache and sore throat, whilst catarrhal symptoms were much less affected.

The administration of Impulsin had no effect on the mean duration of disability and fever, which suggests that the severity of the diseases was not affected.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Pauling, L.: Vitamin C and common cold. J. Amer. med. Ass.216, 332 (1971)

    Google Scholar 

  2. Anderson, T.W., Reid, D.B.W., Beaton, G.H.: Vitamin C and the common cold: a double-blind trial. Can. med. Assoc. J.107, 503–508 (1972)

    Google Scholar 

  3. Wilson, C.W.M., Loh, H.S.: Common cold and vitamin C. Lancet1973 I, 638–641

    Google Scholar 

  4. Merigan, T.C., Hall, T.S., Reed, S.E., Tyrrell, D.A.J.: Inhibition of respiratory virus infection by locally applied interferon. Lancet1973 I, 563–567

    Google Scholar 

  5. Gundy, J.E.: Acellular bacterial antigen complex (Hoffman) in the treatment of children with recurrent respiratory infections and infectious asthma. J. Pediat.51, 516–526 (1957)

    Google Scholar 

  6. Mueller, H.L., Lantz, M.: Hyposensitization with bacterial vaccine in infectious asthma. J. Amer. med. Ass.208, 1379–1383 (1969).

    Google Scholar 

  7. Bachur, N.R., Mašek, K., Melmon, K.L., Udenfriend, S.: Fatty acid amides of ethanolamine in mammalian tissues. J. biol. Chem.240, 1019–1024 (1965)

    Google Scholar 

  8. Rašková, H., Mašek, K.: Nouvelles possibilités d'augmentation de la résistance non-specifique. Thérapie22, 1241–1246 (1967)

    Google Scholar 

  9. Rašková, H., Mašek, K., Linét, O.: Non-specific resistance induced by palmitoylethanolamide. Toxicon10, 485–490 (1972).

    Google Scholar 

  10. Obermajerová, H., Mašek, K., Seifert, J., Buchar, E., Havlík, I.: Structural and functional changes in liver mitochondria of mice fed palmitoylethanolamide (PEA). Biochem. Pharmacol.22, 2529–2536 (1973)

    Google Scholar 

  11. Perlík, F., Elis, J., Rašková, H., Duben, J., Grüblová, M., Kubcová, M., Neubauer, M., Rudolfová, S., Švandová, E., Šamánková, L., Chalabala, M.: A controlled clinical trial with “PEA” in children institutions. (in Czech) Čs. Fysiol.18, 345–346 (1969)

    Google Scholar 

  12. Rowley, D.: Endotoxin-induced changes in susceptibility to infections. In: Bacterial Endotoxins, pp. 359–372 Landy, M., Braun, W. (eds.) New Brunswick 1964, New Jersey

  13. Gledhill, A.W.: Influence of endotoxin upon the pathogenesis of viral infections. In: Bacterial Endotoxins, pp. 410–421 Landy, N. and Braun, W. (eds.). New Brunswick 1964, New Jersey

  14. Cluff, L.E.: Effects of endotoxins on susceptibility to infections. J. infect. Dis.122, 205–215 (1970)

    Google Scholar 

  15. Ransom, J.P., Willner, D.: Resistance enhancing properties against salmonella typhi murium infection and pyrogenic activity of a simple lipid. J. Reticuloendothelial Soc.2, 263–272 (1965)

    Google Scholar 

  16. Crafton, C.G., Di Luzio, N.R.: Relationship of reticuloendothelial functional activity to endotoxin lethality. Amer. J. Physiol.217, 736–742 (1969)

    Google Scholar 

  17. Altura, B.M., Hershey, S.G.: Effects of glyceryl trioleate on the reticuloendothelial system and survival after experimental shock. J. Pharmacol. exp. Ther.175, 555–564 (1970)

    Google Scholar 

  18. Rašková, H., Mašek, K., Linét, O.: Detoxicating properties of a simple lipid compound. Abstracts of Volunteer Papers 5th Int. Congr. Pharmacol., p. 188., San Francisco 1972

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, Czechoslovak Academy of Sciences, Prague, Czechoslovakia

    K. Mašek, F. Perlík, J. Klíma & R. Kahlich

  2. Military Institute of Hygiene, Epidemiology and Microbiology, Prague, Czechoslovakia

    K. Mašek, F. Perlík, J. Klíma & R. Kahlich

Authors
  1. K. Mašek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Perlík
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Klíma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Kahlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Impulsin (N-2-Hydroxyethyl palmitamide) is the product of SPOFA United Pharmaceutical Works.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mašek, K., Perlík, F., Klíma, J. et al. Prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin®) in acute respiratory tract infections. Eur J Clin Pharmacol 7, 415–419 (1974). https://doi.org/10.1007/BF00560353

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00560353

Key words

  • Impulsin
  • non-specific resistance
  • acute respiratory tract infections
  • man